| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |